JSON

All terms in HCAO

Label Id Description
cellular response to iron ion GO_0071281 [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.]
negative regulation of myofibroblast cell apoptotic process GO_1904521 [Any process that stops, prevents or reduces the frequency, rate or extent of myofibroblast cell apoptotic process.]
regulation of myofibroblast cell apoptotic process GO_1904520 [Any process that modulates the frequency, rate or extent of myofibroblast cell apoptotic process.]
positive regulation of myofibroblast cell apoptotic process GO_1904522 [Any process that activates or increases the frequency, rate or extent of myofibroblast cell apoptotic process.]
Afrotheria NCBITaxon_311790
negative regulation of microtubule binding GO_1904527 [Any process that stops, prevents or reduces the frequency, rate or extent of microtubule binding.]
regulation of microtubule binding GO_1904526 [Any process that modulates the frequency, rate or extent of microtubule binding.]
positive regulation of microtubule binding GO_1904528 [Any process that activates or increases the frequency, rate or extent of microtubule binding.]
cellular response to calcium ion GO_0071277 [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.]
response to calcium ion GO_0051592 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.]
acetamides CHEBI_22160 [Compounds with the general formula RNHC(=O)CH3.]
immunological adjuvant CHEBI_50847 [A substance that augments, stimulates, activates, potentiates, or modulates the immune response at either the cellular or humoral level. A classical agent (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contains bacterial antigens. It could also be endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Its mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy is related to its antigen-specific immunoadjuvanticity.]
radical scavenger CHEBI_48578 [A role played by a substance that can react readily with, and thereby eliminate, radicals.]
geroprotector CHEBI_176497 [Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.]
anticonvulsant CHEBI_35623 [A drug used to prevent seizures or reduce their severity.]
saturated fatty acid CHEBI_26607 [Any fatty acid containing no carbon to carbon multiple bonds. Known to produce adverse biological effects when ingested to excess.]
straight-chain fatty acid CHEBI_59202 [Any fatty acid whose skeletal carbon atoms form an unbranched open chain.]
regulation of acinar cell proliferation GO_1904697 [Any process that modulates the frequency, rate or extent of acinar cell proliferation.]
acinar cell proliferation GO_1990863 [The multiplication or reproduction of acinar cells, resulting in the expansion of a cell population. An acinar cell is a secretory cell that is grouped together with other cells of the same type to form grape-shaped clusters known as acini (singular acinus).]
negative regulation of hematopoietic stem cell proliferation GO_1902034 [Any process that stops, prevents or reduces the frequency, rate or extent of hematopoietic stem cell proliferation.]